Inhalation of tobramycin using simulated cystic fibrosis patient profiles
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhalation of tobramycin using simulated cystic fibrosis patient profiles
Authors
Keywords
-
Journal
PEDIATRIC PULMONOLOGY
Volume 51, Issue 11, Pages 1159-1167
Publisher
Wiley
Online
2016-05-02
DOI
10.1002/ppul.23451
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Vitro–In VivoCorrelations Observed With Indacaterol-Based Formulations Delivered with the Breezhaler®
- (2015) Jeffry G. Weers et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Inhaled antibiotics: dry or wet?
- (2014) H. A. W. M. Tiddens et al. EUROPEAN RESPIRATORY JOURNAL
- Inhaled versus nebulised tobramycin: A real world comparison in adult cystic fibrosis (CF)
- (2014) M.J. Harrison et al. Journal of Cystic Fibrosis
- Comparison of In Vitro Deposition of Pharmaceutical Aerosols in an Idealized Child Throat with In Vivo Deposition in the Upper Respiratory Tract of Children
- (2014) Conor A. Ruzycki et al. PHARMACEUTICAL RESEARCH
- Validation of a General In Vitro Approach for Prediction of Total Lung Deposition in Healthy Adults for Pharmaceutical Inhalation Products
- (2013) Bo Olsson et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Treatment complexity in cystic fibrosis: Trends over time and associations with site-specific outcomes
- (2013) Gregory S. Sawicki et al. Journal of Cystic Fibrosis
- In Vitro Tests for Aerosol Deposition II: IVIVCs for Different Dry Powder Inhalers in Normal Adults
- (2012) Renishkumar Delvadia et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Managing treatment complexity in cystic fibrosis: Challenges and Opportunities
- (2012) Gregory S. Sawicki et al. PEDIATRIC PULMONOLOGY
- What the pulmonary specialist should know about the new inhalation therapies
- (2011) B. L. Laube et al. EUROPEAN RESPIRATORY JOURNAL
- Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology
- (2011) David E. Geller et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Adherence with tobramycin inhaled solution and health care utilization
- (2011) Becky A Briesacher et al. BMC Pulmonary Medicine
- Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol
- (2010) Richard Pavkov et al. CURRENT MEDICAL RESEARCH AND OPINION
- Pulmonary Formulations: What Remains to be Done?
- (2010) Jeffry G. Weers et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Lung deposition of inhaled tobramycin with eFlow rapid/LC Plus jet nebuliser in healthy and cystic fibrosis subjects
- (2010) Warren Lenney et al. Journal of Cystic Fibrosis
- Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial
- (2010) Michael W. Konstan et al. Journal of Cystic Fibrosis
- Inhaled Mannitol Improves Lung Function in Cystic Fibrosis
- (2008) Anna Jaques et al. CHEST
- Respiratory muscle strength in stable adolescent and adult patients with cystic fibrosis
- (2008) M.A. Dunnink et al. Journal of Cystic Fibrosis
- High treatment burden in adults with cystic fibrosis: Challenges to disease self-management
- (2008) Gregory S. Sawicki et al. Journal of Cystic Fibrosis
- Inspiratory flow rates at different levels of resistance in elderly COPD patients
- (2007) W. Janssens et al. EUROPEAN RESPIRATORY JOURNAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started